BioCentury | Apr 12, 2021
Product Development
COVID Quick Takes: subcutaneous Regeneron mAbs prevent symptomatic COVID; plus Pfizer-BionTech, J&J, Akili and Kiniksa
...By Sandi Wong, Assistant Editor Regeneron reported Phase...
...to more severe disease. In the trial, which Regeneron Pharmaceuticals Inc....
...BNT162, BNT162b2) COVID-19 Vaccine Janssen (Ad26.COV2.S, JNJ-78436735) mavrilimumab (cam-3001) AKL-T01, SDT-001 Regeneron Pharmaceuticals Inc. Pfizer...
...to more severe disease. In the trial, which Regeneron Pharmaceuticals Inc....
...BNT162, BNT162b2) COVID-19 Vaccine Janssen (Ad26.COV2.S, JNJ-78436735) mavrilimumab (cam-3001) AKL-T01, SDT-001 Regeneron Pharmaceuticals Inc. Pfizer...